The Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) as Expression of the Relationship between Microglia and Alzheimer's Disease: A Novel Marker for a Promising Pathway to Explore
- PMID: 30997915
- PMCID: PMC12275730
- DOI: 10.14283/jfa.2018.43
The Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) as Expression of the Relationship between Microglia and Alzheimer's Disease: A Novel Marker for a Promising Pathway to Explore
Abstract
Alzheimer's disease (AD) is a common neurodegenerative disorder, strongly related with age. It has been reported that genetic variants of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2), a cell-surface receptor expressed in microglial cells, greatly increase the risk of AD, thus suggesting an involvement of the microglia in the AD pathogenesis. The aim of this report is to provide an overview of the TREM2 and of its possible implication in the pathogenesis of AD.
Keywords: Alzheimer’s disease; Triggering Receptor Expressed on Myeloid cells-2; aging; microglia.
References
-
- Canevelli M, Trebbastoni A, Quarata F, D'Antonio F, Cesari M d, Lena C, Bruno G. External Validity of Randomized Controlled Trials on Alzheimer's Disease: The Biases of Frailty and Biological Aging. Front Neurol. 2017;8:628. 10.3389/fneur.2017.00628 PubMed PMID: 29230192, PMCID 5712065. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical